Prednisolone Sodium Phosphate NDC 0121-0759

NDC codes

FDA NDC Directory

Product NDC (as listed)0121-0759Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00121-0759Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0121-0759-08	00121075908	237 mL in 1 BOTTLE (0121-0759-08)Marketed from Apr 25, 2005

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Prednisolone Sodium Phosphate
Generic name (nonproprietary): prednisolone sodium phosphate
Active ingredients: Prednisolone sodium phosphate — 15 mg/5mL
Dosage form: Solution
Route: Oral
Labeler: PAI Holdings, LLC dba PAI Pharma
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076913
Marketing start: Apr 25, 2005
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 0121-0759_07592713-8b0b-47aa-8a7f-848823ff221cSPL ID 07592713-8b0b-47aa-8a7f-848823ff221cSPL set ID a0d74ae0-7b2d-4d36-9211-c76f5063b5a9RxCUI 283077UNII IV021NXA9JUPC 0301210759086
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400121075908 followed by a unit qualifier and the quantity

Package 00121-0759-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 10, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Prednisolone sodium phosphate oral solution is indicated in the following conditions: 1. Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in adult and pediatric populations with: seasonal or perennial allergic rhinitis; asthma; contact dermatitis; atopic dermatitis; serum sickness; drug hypersensitivity reactions. 2. Dermatologic Diseases Pemphigus; bullous dermatitis herpetiformis; severe erythema multiforme (Stevens-Johnson syndrome); exfoliative erythroderma; mycosis fungoides. 3. Edematous States To induce diuresis or remission of proteinuria in nephrotic syndrome in adults with lupus er…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 076913

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076913
Product	Strength	Form · route	Labeler	Product NDC
Prednisolone Sodium Phosphate	Prednisolone sodium phosphate 15 mg/5mL	SolutionOral	Proficient Rx LP	63187-215
Prednisolone Sodium Phosphate	Prednisolone sodium phosphate 15 mg/5mL	SolutionOral	REMEDYREPACK INC.	70518-4524
Prednisolone Sodium Phosphate	Prednisolone sodium phosphate 15 mg/5mL	SolutionOral	Preferred Pharmaceuticals, Inc.	68788-7708
Prednisolone Sodium Phosphate	Prednisolone sodium phosphate 15 mg/5mL	SolutionOral	PAI Holdings, LLC dba PAI Pharma	0121-4759
Prednisolone Sodium Phosphate	Prednisolone sodium phosphate 15 mg/5mL	SolutionOral	A-S Medication Solutions	50090-1582